title: Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.
authors.affiliation: Department of Anesthesiology, Louisiana State University Health Science Center , New Orleans, LA , USA.
authors.forename: Xiulu
authors.initials: X
authors.lastname: Ruan
authors.affiliation: Departments of Neurology and Pharmacology, Lewis Katz, School of Medicine at Temple University , Philadelphia, PA , USA.
authors.forename: Jin Jun
authors.initials: JJ
authors.lastname: Luo
authors.affiliation: Department of Anesthesiology, Louisiana State University Health Science Center , New Orleans, LA , USA.
authors.forename: Alan David
authors.initials: AD
authors.lastname: Kaye
keywords: FDA; buprenorphine; hypnotics and sedatives; opioid withdrawal syndrome; overdose; suicide